calcipotriene 0.005 % Topical Foam

RxCUI: 1020035
RxNorm name: calcipotriene 0.005 % Topical Foam
Display name: calcipotriene 0.005 % Topical Foam
Full name: calcipotriene 0.005 % Topical Foam
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
calcipotriene	CALCIPOTRIENE	Mayne Pharma	26756ac7-a80c-49db-97bb-351f76ad8a71	2024-05-09	Warnings, Adverse reactions	Exact identifier rxcui: 1020035
SORILUX	CALCIPOTRIENE	Mayne Pharma	51f208d0-7b3f-44cc-8bed-92fa3d2e7bbe	2024-05-09	Warnings, Adverse reactions	Exact identifier rxcui: 1020035

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
51f208d0-7b3f-44cc-8bed-92fa3d2e7bbe	calcipotriene 0.005 % Topical Foam	PSN	7	These highlights do not include all the information needed to use SORILUX safely and effectively. See full prescribing information for SORILUX. SORILUX (calcipotriene) foam, for topical use Initial U.S. Approval: 1993	20240509
51f208d0-7b3f-44cc-8bed-92fa3d2e7bbe	calcipotriene 0.05 MG/ML Topical Foam	SCD	7	These highlights do not include all the information needed to use SORILUX safely and effectively. See full prescribing information for SORILUX. SORILUX (calcipotriene) foam, for topical use Initial U.S. Approval: 1993	20240509
51f208d0-7b3f-44cc-8bed-92fa3d2e7bbe	calcipotriene 0.005 % Topical Foam	SY	7	These highlights do not include all the information needed to use SORILUX safely and effectively. See full prescribing information for SORILUX. SORILUX (calcipotriene) foam, for topical use Initial U.S. Approval: 1993	20240509
26756ac7-a80c-49db-97bb-351f76ad8a71	calcipotriene 0.05 MG/ML Topical Foam	SCD	4	These highlights do not include all the information needed to use calcipotriene foam safely and effectively. See full prescribing information for calcipotriene foam. CALCIPOTRIENE foam, for topical use Initial U.S. Approval: 1993	20240509
26756ac7-a80c-49db-97bb-351f76ad8a71	calcipotriene 0.005 % Topical Foam	PSN	4	These highlights do not include all the information needed to use calcipotriene foam safely and effectively. See full prescribing information for calcipotriene foam. CALCIPOTRIENE foam, for topical use Initial U.S. Approval: 1993	20240509
26756ac7-a80c-49db-97bb-351f76ad8a71	calcipotriene 0.005 % Topical Foam	SY	4	These highlights do not include all the information needed to use calcipotriene foam safely and effectively. See full prescribing information for calcipotriene foam. CALCIPOTRIENE foam, for topical use Initial U.S. Approval: 1993	20240509